xamoterol has been researched along with Heart Failure in 74 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (44.59) | 18.7374 |
| 1990's | 37 (50.00) | 18.2507 |
| 2000's | 4 (5.41) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Böhm, M; Dabew, E; Engelhardt, S; Lohse, MJ; Lorenz, K; Maack, C; Schäfers, HJ; Vlaskin, L | 1 |
| Fukushima, M; Matsumoto, M; Matsuyama, T; Ozaki, H; Sato, H | 1 |
| Detry, JM; Mancia, G; Pouleur, H | 1 |
| Bergler-Klein, J; Glogar, D; Pacher, R; Porenta, G; Pouleur, H; Sochor, H | 1 |
| Erhardt, L; Melcher, A; Persson, H; Rythe'n-Alder, E | 1 |
| MacFadyen, RJ | 1 |
| Bøtker, HE; Jensen, HK; Krusell, LR; Sørensen, EV | 1 |
| Shah, R | 1 |
| Aiyar, N; Disa, J; Mitchell, MP; Naselsky, DP; Ohlstein, EH; Ruffolo, RR; Stadel, JM; Storer, BL; Willette, RN; Yue, TL | 1 |
| Carson, PE | 1 |
| Cobelli, F; Febo, O | 1 |
| Poole-Wilson, PA; van Veldhuisen, DJ | 1 |
| Andréasson, K; Erhardt, L; Eriksson, SV; Hall, C; Hjemdahl, P; Kahan, T; Persson, H; Tidgren, B | 1 |
| Hayashida, W; Kawai, C; Kumada, T | 1 |
| Lyngborg, K; Mehlsen, J; Svendsen, TL; Tangø, M; Trap-Jensen, J | 1 |
| Eber, B; Klein, W; Rotman, B | 1 |
| Hori, M; Imai, K; Inoue, M; Kamada, T; Kitabatake, A; Matsuyama, T; Ozaki, H; Sato, H; Yokoyama, H | 1 |
| Kupper, W | 1 |
| Anfilogoff, NH; Davies, MK; Littler, WA; Murray, RG; Qiang, FX; Virk, SJ | 1 |
| Fowler, G; Jamieson, MJ; Petrie, JC; Rawles, J; Smith, FW; Webster, J | 1 |
| Bleifeld, W; Erlemeier, HH; Kupper, W | 3 |
| Limas, C; Limas, CJ | 1 |
| Hasenfuss, G; Holubarsch, C; Just, H; Thierfelder, L | 1 |
| Etienne, J; Gurné, O; Pouleur, H; Rousseau, MF; Van Mechelen, H | 1 |
| Marlow, HF | 3 |
| Fournier, P; Fraysse, JB; Grosgogeat, Y; Komajda, M; Landault, C; Lechat, P; Richaud, M | 1 |
| Heng, MK | 1 |
| Böhm, M; Erdmann, E; Schwinger, RH | 1 |
| Hanet, C; Pouleur, H; Rousseau, MF | 2 |
| Crozier, IG; Ikram, H | 1 |
| Faergeman, O; Vigholt-Sørensen, E | 1 |
| Hasenfuss, G; Holubarsch, CH; Just, HJ; Thierfelder, L | 1 |
| Böhm, M; Erdmann, E; Mittmann, C; Schwinger, RH | 1 |
| Anfilogoff, NH; Davies, MK; Lawson, N; Littler, WA; Murray, RG; Qiang, F; Virk, SJ | 1 |
| Shabetai, R | 1 |
| Barker, NP; Bastain, W; Channer, KS; Harry, JD; James, MA; Jones, JV; Marlow, HF; Papouchado, M; Wardleworth, AG | 1 |
| Armstrong, C; Blackwood, R; Bryant, B; Garnham, JC; Mayou, RA | 1 |
| Heusch, G; Linder, C; Schäfer, S | 1 |
| Heinzl, S | 1 |
| Timmis, AD | 1 |
| Anfilogoff, NH; Davies, MK; Lawson, N; Littler, WA; Murray, RG; Nuttall, A; Sadler, AM; Smith, SJ; Virk, SJ | 1 |
| Bounhoure, JP; Doat, P; Fauvel, JM; Grenet, B; Kayanakis, JG; Larouchi, L | 1 |
| Francis, GS | 1 |
| Davies, MK; Virk, SJ | 1 |
| Parmley, WW | 1 |
| Gurné, O; Hanet, C; Pouleur, H; Rousseau, MF | 1 |
| Waller, DG | 1 |
| Bastain, W; Marlow, HF | 1 |
| Campbell, RW | 1 |
| France, LA; Green, FL; Snow, HM | 1 |
| Day, MA; Faergeman, O; Snow, HM; Sørensen, EV | 1 |
| Faergeman, O; Snow, HM; Vigholt-Sørensen, E | 1 |
| Bhalla, KK; Sykes, CA; Waller, DG; Webster, J; Wray, R | 1 |
| Andersen, MF; Faergeman, O; Sorensen, EV; Sterndorff, B | 1 |
| Cheron, P; Lavenne, F; Nannan, M; Pouleur, H; Rousseau, MF; Vincent, MF | 1 |
| Aumont, MC; Castaigne, A | 1 |
| Bastain, W; Petrie, JC; Scott, AK; Webster, J | 1 |
| von Olshausen, K | 1 |
| Fukuda, K; Handa, S; Kawamura, Y; Nakamura, Y; Ogawa, S | 1 |
| Hirokawa, Y; Shibata, A; Watanabe, K | 1 |
23 review(s) available for xamoterol and Heart Failure
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Role of the circulating and tissue-based renin-angiotensin system in the development of heart failure: implications for therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Enalapril; Heart Failure; Hemodynamics; Humans; Renin-Angiotensin System; Survival Rate; Ventricular Function, Left; Xamoterol | 1993 |
CPMP note for guidance: clinical trials on the medicinal products in the treatment of cardiac failure.
Topics: Adrenergic beta-Agonists; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Follow-Up Studies; Guidelines as Topic; Heart Failure; Humans; Isoenzymes; Phosphodiesterase Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; United Kingdom; Xamoterol | 1996 |
Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol | 1999 |
[Exercise test in the evaluation of the efficacy of drug therapy].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Digitalis; Evaluation Studies as Topic; Exercise Test; Follow-Up Studies; Heart Failure; Humans; Oxygen Consumption; Plants, Medicinal; Plants, Toxic; Time Factors; Vasodilator Agents; Xamoterol | 2000 |
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure.
Topics: Bosentan; Cardiovascular Agents; Deoxyepinephrine; Heart Failure; Humans; Imidazoles; Mibefradil; Pyrazines; Quinolines; Sulfonamides; Xamoterol | 2001 |
[New oral drugs for the treatment of congestive heart failure].
Topics: Administration, Oral; Cardiotonic Agents; Deoxyepinephrine; Ethanolamines; Heart Failure; Humans; Phosphodiesterase Inhibitors; Piperidines; Propanolamines; Pyrazines; Quinolines; Quinolones; Vasodilator Agents; Xamoterol | 1992 |
Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
Topics: Adrenergic beta-Agonists; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Contraction; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Xamoterol | 1990 |
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol | 1990 |
Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Myocardial Contraction; Propanolamines; Xamoterol | 1990 |
Selective beta-1-adrenoceptor partial agonist treatment for congestive heart failure.
Topics: Adrenergic beta-Agonists; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Propanolamines; Ventricular Function, Left; Xamoterol | 1990 |
Xamoterol--more trouble than it's worth?
Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol | 1990 |
The efficacy of xamoterol in heart failure of ischemic origin.
Topics: Adrenergic beta-Agonists; Coronary Disease; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |
[Heart failure. New knowledge on pathophysiology and therapy].
Topics: Heart; Heart Failure; Hemodynamics; Humans; Propanolamines; Xamoterol | 1989 |
A new look at digoxin in congestive heart failure and sinus rhythm.
Topics: Arrhythmia, Sinus; Blood Circulation; Cardiac Glycosides; Digoxin; Heart Failure; Humans; Myocardial Contraction; Propanolamines; Xamoterol | 1989 |
The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Propanolamines; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sympathetic Nervous System; Xamoterol | 1989 |
Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |
Treatment of congestive heart failure--state of the art and future trends.
Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |
Focus on diastolic dysfunction: a new approach to heart failure therapy.
Topics: Adrenergic beta-Agonists; Animals; Diastole; Heart Failure; Humans; Myocardial Contraction; Propanolamines; Xamoterol | 1989 |
Long-term studies with xamoterol in heart failure.
Topics: Adrenergic beta-Agonists; Chronic Disease; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |
The management of heart failure and the scope for new therapies: what role for xamoterol?
Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |
[Cardiac insufficiency. Current treatment].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Heart Failure; Humans; Propanolamines; Xamoterol | 1988 |
Xamoterol: stabilising the cardiac beta receptor?
Topics: Adrenergic beta-Agonists; Chronic Disease; Heart Failure; Hemodynamics; Humans; Propanolamines; Receptors, Adrenergic, beta; Xamoterol | 1988 |
27 trial(s) available for xamoterol and Heart Failure
| Article | Year |
|---|---|
Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Potassium; Prospective Studies; Xamoterol | 1994 |
Effects of beta receptor antagonists in patients with clinical evidence of heart failure after myocardial infarction: double blind comparison of metoprolol and xamoterol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Prospective Studies; Xamoterol | 1995 |
Renal effects of xamoterol in patients with moderate heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Diuresis; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Potassium; Sodium; Xamoterol | 1993 |
Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Chi-Square Distribution; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Doppler; Epinephrine; Female; Follow-Up Studies; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Neuropeptide Y; Norepinephrine; Probability; Proportional Hazards Models; Prospective Studies; Survival Rate; Treatment Outcome; Xamoterol | 2002 |
Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised study.
Topics: Administration, Oral; Adrenergic beta-Agonists; Aged; Body Weight; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Oxygen Consumption; Propanolamines; Xamoterol | 1992 |
Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Time Factors; Xamoterol | 1992 |
Predominant beta-adrenoceptor blocking effect of xamoterol averaged over the day in patients with mild to moderate heart failure: insight into the mechanism of its long-term clinical efficacy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Circadian Rhythm; Electrocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Stimulation, Chemical; Sympathetic Nervous System; Time Factors; Xamoterol | 1992 |
Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Electrocardiography, Ambulatory; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Xamoterol | 1991 |
A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
Topics: Adrenergic beta-Agonists; Aged; Blood Pressure; Cardiac Output; Double-Blind Method; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Iodine Radioisotopes; Kidney; Kidney Function Tests; Male; Middle Aged; Propanolamines; Renal Circulation; Renin; Vascular Resistance; Xamoterol | 1991 |
Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
Topics: Activities of Daily Living; Adrenergic beta-Agonists; Aged; Analysis of Variance; Blood Pressure; Cardiac Complexes, Premature; Discriminant Analysis; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Randomized Controlled Trials as Topic; Research Design; Tachycardia; Xamoterol | 1990 |
Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
Topics: Adrenergic beta-Agonists; Cardiac Complexes, Premature; Coronary Disease; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Renin; Time Factors; Xamoterol | 1990 |
Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
Topics: Adrenergic beta-Agonists; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Contraction; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Xamoterol | 1990 |
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol | 1990 |
[Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease].
Topics: Adrenergic beta-Agonists; Adult; Cardiac Output; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Norepinephrine; Propanolamines; Renin; Xamoterol | 1990 |
Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
Topics: Administration, Oral; Adrenergic beta-Agonists; Blood Pressure; Cardiac Output; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Norepinephrine; Propanolamines; Pulmonary Wedge Pressure; Randomized Controlled Trials as Topic; Renin; Xamoterol | 1990 |
Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol.
Topics: Adrenergic beta-Agonists; Adult; Aged; Double-Blind Method; Exercise; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Time Factors; Xamoterol | 1990 |
The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Circadian Rhythm; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Regression Analysis; Xamoterol | 1990 |
The effect of oral dosing of xamoterol on systolic time intervals in man and xamoterol plasma concentrations in heart failure patients.
Topics: Adult; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Heart Failure; Heart Rate; Humans; Male; Myocardial Contraction; Propanolamines; Xamoterol | 1990 |
Exercise capacity and quality of life in the treatment of heart failure.
Topics: Adult; Aged; Digoxin; Exercise; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Quality of Life; Randomized Controlled Trials as Topic; Xamoterol | 1990 |
[Effects of xamoterol in moderate cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Placebos; Propanolamines; Random Allocation; Xamoterol | 1989 |
The effects of age, sex and treatment with xamoterol on exercise capacity in patients with heart failure.
Topics: Adrenergic beta-Agonists; Aging; Exercise; Female; Heart Failure; Humans; Male; Propanolamines; Random Allocation; Sex Factors; Xamoterol | 1989 |
Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
Topics: Adrenergic beta-Agonists; Aged; Double-Blind Method; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Xamoterol | 1989 |
Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
Topics: Adrenergic beta-Agonists; Adult; Aged; Cardiac Output, Low; Coronary Disease; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic; Xamoterol | 1989 |
Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
Topics: Adrenergic beta-Agonists; Adult; Aged; Angina Pectoris; Coronary Disease; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Quality of Life; Randomized Controlled Trials as Topic; Single-Blind Method; Xamoterol | 1989 |
Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
Topics: Adrenergic beta-Agonists; Adult; Aged; Digoxin; Double-Blind Method; Echocardiography; Electrocardiography; Exercise Test; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Xamoterol | 1989 |
Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Digoxin; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Random Allocation; Xamoterol | 1988 |
Xamoterol in heart failure.
Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol | 1988 |
26 other study(ies) available for xamoterol and Heart Failure
| Article | Year |
|---|---|
Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atrial Function; Heart Atria; Heart Failure; Heart Rate; Humans; In Vitro Techniques; Male; Metoprolol; Mice; Mice, Transgenic; Middle Aged; Myocardial Contraction; Organ Specificity; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Species Specificity; Xamoterol | 2003 |
[Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure].
Topics: Adrenergic beta-Agonists; Adult; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Sympathetic Nervous System; Xamoterol | 1984 |
Inotropic drugs of the future.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Imidazoles; Practolol; Prenalterol; Propanolamines; Xamoterol | 1982 |
In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Bisoprolol; Carbazoles; Carvedilol; Cell Membrane; Cells, Cultured; Cyclic AMP; Decerebrate State; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Iodocyanopindolol; Ligands; Male; Myocardium; Propanolamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Xamoterol | 1999 |
Interrupting the adaptive changes in congestive heart failure.
Topics: Adrenergic beta-Agonists; Animals; Down-Regulation; Heart; Heart Failure; Heart Rate; Humans; Pressoreceptors; Propanolamines; Rats; Receptors, Adrenergic, beta; Xamoterol | 1991 |
Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cell-Free System; Colchicine; Cytochalasin B; Heart; Heart Failure; Heparin; Isoproterenol; Myocardium; Propanolamines; Protein Kinases; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Xamoterol | 1990 |
Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
Topics: Benzazepines; Cardiotonic Agents; Energy Metabolism; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Propanolamines; Vasodilator Agents; Xamoterol | 1991 |
Effects of the beta 1-adrenergic receptor partial agonist xamoterol on left ventricular diastolic function. An evaluation after 1-6 years of oral therapy.
Topics: Administration, Oral; Adrenergic beta-Agonists; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors; Xamoterol | 1990 |
The effect of xamoterol in failing human myocardium.
Topics: Adrenergic beta-Agonists; Aged; Cardiac Surgical Procedures; Electric Stimulation; Female; Heart Failure; Hemodynamics; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Myocardium; Propanolamines; Xamoterol | 1990 |
Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
Topics: Adrenergic beta-Agonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Diastole; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Systole; Xamoterol | 1990 |
New evidence on xamoterol.
Topics: Adrenergic beta-Agonists; Drug Evaluation; Heart Failure; Humans; Propanolamines; Xamoterol | 1990 |
Xamoterol in severe heart failure.
Topics: Adrenergic beta-Agonists; Heart Failure; Humans; Propanolamines; Xamoterol | 1990 |
Myocardial energetics in dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Enoximone; Heart; Heart Failure; Heart Rate; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Propanolamines; Pyridazines; Stroke Volume; Vascular Resistance; Vasodilator Agents; Xamoterol | 1990 |
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Dose-Response Relationship, Drug; Heart Atria; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Pindolol; Propanolamines; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Xamoterol | 1990 |
Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery.
Topics: Animals; Blood Pressure; Dogs; Electrolytes; Female; Heart; Heart Failure; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Propanolamines; Vagotomy; Xamoterol | 1990 |
The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Cardiac Output; Drug Evaluation; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Propanolamines; Pulmonary Wedge Pressure; Stroke Volume; Time Factors; Vascular Resistance; Xamoterol | 1989 |
Xamoterol, a beta1-adrenoceptor partial agonist: a new approach to heart failure. Proceedings of the 1st International Heart Failure. Interlaken, 1988.
Topics: Adrenergic beta-Agonists; Animals; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |
Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Topics: Adrenergic beta-Agonists; Blood Pressure; Chronic Disease; Exercise; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Vascular Resistance; Xamoterol | 1989 |
The effect of age and renal impairment on the pharmacokinetics of xamoterol.
Topics: Adrenergic beta-Agonists; Adult; Aging; Creatinine; Heart Failure; Humans; Kidney Diseases; Male; Middle Aged; Propanolamines; Xamoterol | 1989 |
Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Cardiomegaly; Exercise Test; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |
The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.
Topics: Adrenergic beta-Agonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Xamoterol | 1989 |
[Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Coronary Disease; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Propanolamines; Tachyphylaxis; Time Factors; Xamoterol | 1985 |
Xamoterol versus digoxin in heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Digoxin; Heart Failure; Humans; Middle Aged; Propanolamines; Xamoterol | 1988 |
The effect of age and cardiac failure on xamoterol pharmacokinetics.
Topics: Adrenergic beta-Agonists; Adult; Age Factors; Aged; Aged, 80 and over; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Xamoterol | 1988 |
[Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Circadian Rhythm; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Xamoterol | 1988 |
Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Adult; Cardiomyopathy, Dilated; Female; Heart Failure; Hemodynamics; Humans; Lymphocytes; Male; Middle Aged; Physical Exertion; Propanolamines; Receptors, Adrenergic, beta; Xamoterol | 1988 |